RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT)

Q: What does CUSIP 75382E109 represent in this 13F holders report?

CUSIP 75382E109 is the security identifier for RAPT - RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held RAPT - RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share in Q4 2021?

96 institutional investors reported RAPT - RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share for Q4 2021. Use the holders table for investor-level position and value details.

CUSIP: 75382E109

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock $0.0001 par value per share
Shares outstanding: 27,725,634
Total 13F shares: 26,299,986
Share change: +1,509,925
Total reported value: $965,984,248
Put/Call ratio: 3.6%
Price per share: $36.73
Number of holders: 96
Value change: +$58,612,650
Number of buys: 40
Number of sells: 53

Quarterly Holders Quick Answers

What is CUSIP 75382E109?
CUSIP 75382E109 identifies RAPT - RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 75382E109:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of RAPT - RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	14%	3,902,178	$121,163,000	—	30 Sep 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	10%	2,907,565	$90,280,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	6.8%	1,898,821	$58,957,000	—	30 Sep 2021	13F
Ponoi Management, LLC	13F	Company	5.8%	1,599,417	$49,662,000	—	30 Sep 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.4%	1,507,203	$46,798,000	—	30 Sep 2021	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	4.1%	1,148,321	$35,655,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	4.1%	1,141,129	$35,432,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	3.9%	1,078,886	$33,499,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	2.8%	763,744	$23,714,000	—	30 Sep 2021	13F
Alphabet Inc.	13F	Company	2.6%	710,250	$22,053,000	—	30 Sep 2021	13F
Euclidean Capital LLC	13F	Company	2.3%	635,177	$19,722,000	—	30 Sep 2021	13F
Of The University Of California Regents	13F	Individual	2.2%	608,663	$18,899,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.8%	496,407	$15,413,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	346,867	$10,770,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	1.2%	344,837	$10,707,000	—	30 Sep 2021	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	1%	287,900	$8,939,000	—	30 Sep 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.9%	250,800	$7,787,000	—	30 Sep 2021	13F
Ghost Tree Capital, LLC	13F	Company	0.9%	250,000	$7,763,000	—	30 Sep 2021	13F
NORGES BANK	13F	Company	0.87%	240,700	$7,474,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.78%	217,198	$6,745,000	—	30 Sep 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.76%	211,336	$6,562,000	—	30 Sep 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.71%	196,434	$6,099,000	—	30 Sep 2021	13F
HealthCor Management, L.P.	13F	Company	0.67%	184,700	$5,735,000	—	30 Sep 2021	13F
SG Americas Securities, LLC	13F	Company	0.58%	160,250	$4,976,000	—	30 Sep 2021	13F
Ponoi II Management, LLC	13F	Company	0.52%	145,401	$4,515,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.51%	140,134	$4,352,000	—	30 Sep 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.46%	127,768	$3,967,000	—	30 Sep 2021	13F
MARSHALL WACE, LLP	13F	Company	0.43%	120,094	$3,729,000	—	30 Sep 2021	13F
Pentwater Capital Management LP	13F	Company	0.41%	115,000	$3,571,000	—	30 Sep 2021	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.41%	113,398	$3,522,000	—	30 Sep 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.4%	111,536	$3,463,000	—	30 Sep 2021	13F
Marshall Wace North America L.P.	13F	Company	0.38%	105,614	$3,280,000	—	30 Sep 2021	13F
AJU IB Investment Co., Ltd.	13F	Company	0.36%	99,503	$3,090,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.58%	160,934	$2,988,000	—	30 Sep 2021	13F
Walleye Capital LLC	13F	Company	0.33%	91,227	$2,833,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.31%	84,727	$2,631,000	—	30 Sep 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.3%	83,640	$2,597,000	—	30 Sep 2021	13F
Trustees of Columbia University in the City of New York	13F	Company	0.26%	73,383	$2,279,000	—	30 Sep 2021	13F
Invesco Ltd.	13F	Company	0.21%	58,304	$1,811,000	—	30 Sep 2021	13F
Maven Securities LTD	13F	Company	0.18%	50,000	$1,553,000	—	30 Sep 2021	13F
SIMPLEX TRADING, LLC	13F	Company	0.17%	47,784	$1,469,000	—	30 Sep 2021	13F
Jasper Ridge Partners, L.P.	13F	Company	0.16%	45,650	$1,417,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.15%	41,300	$1,282,000	—	30 Sep 2021	13F
Informed Momentum Co LLC	13F	Company	0.14%	40,000	$1,242,000	—	30 Sep 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.14%	38,200	$1,186,000	—	30 Sep 2021	13F
ALPS ADVISORS INC	13F	Company	0.13%	36,139	$1,122,000	—	30 Sep 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.13%	35,016	$1,087,000	—	30 Sep 2021	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.12%	33,423	$1,038,000	—	30 Sep 2021	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.12%	32,483	$1,009,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	31,563	$980,000	—	30 Sep 2021	13F

Institutional Holders of RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT) as of Q4 2021

As of 31 Dec 2021, RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,299,986 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, FMR LLC, BlackRock Inc., Ponoi Management, LLC, Column Group LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, VANGUARD GROUP INC, and KINGDON CAPITAL MANAGEMENT, L.L.C.. This page lists 96 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

104

Q4 2021 holders

Holder diff

-8

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.